They will NOT pay for anything off-label as I previously reported on this board (for me, analgesic/anti-inflammatory benefits). And yes, generics first.
I hope AMRN is educating CVS at least for indicated cardio patients with their current label - what generic exists that isn't a DS for clinical (FDA regulated) EPA EE in the US? None that I'm aware of.
Regarding generic cartels (over 300 drugs caught up in the net) in the US - today in the WAPO(MSN) - I know we're all cynical about efforts to chase wrong-doers by the Feds, but price-fixing does get busted:
Market Data 
Markets 
AI
